| Literature DB >> 29752652 |
Katsuyuki Yokoi1,2, Yoko Nakajima1, Tamae Ohye2, Hidehito Inagaki2, Yoshinao Wada3, Tokiko Fukuda4, Hideo Sugie5, Isao Yuasa6, Tetsuya Ito1, Hiroki Kurahashi7,8,9.
Abstract
Phosphoglucomutase 1 (PGM1) deficiency is a recently defined disease characterized by glycogenosis and a congenital glycosylation disorder caused by recessive mutations in the PGM1 gene. We report a case of a 12-year-old boy with first-cousin parents who was diagnosed with a PGM1 deficiency due to significantly decreased PGM1 activity in his muscle. However, Sanger sequencing revealed no pathogenic mutation in the PGM1 gene in this patient. As this case presented with a cleft palate in addition to hypoglycemia and elevated transaminases and creatine kinase, karyotyping was performed and identified homozygous inv(1)(p31.1p32.3). Based on the chromosomal location of the PGM1 gene at 1p31, we analyzed the breakpoint of the inversion. Fluorescence in situ hybridization (FISH) combined with long PCR analysis revealed that the inversion disrupts the PGM1 gene within intron 1. Since the initiation codon in the PGM1 gene is located within exon 1, we speculated that this inversion inactivates the PGM1 gene and was therefore responsible for the patient's phenotype. When standard molecular testing fails to reveal a mutation despite a positive clinical and biochemical diagnosis, the presence of a gross structural variant that requires karyotypic examination must be considered.Entities:
Keywords: Chromosomal inversion; Congenital disorders of glycosylation; Hypoglycemia; PGM1; Phosphoglucomutase 1 deficiency
Year: 2018 PMID: 29752652 PMCID: PMC6323009 DOI: 10.1007/8904_2018_108
Source DB: PubMed Journal: JIMD Rep ISSN: 2192-8304